This is a firm fixed-price delivery order (SPE2DB20D9759|SPE2DB25FD5JS) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $5,920.00, is for the delivery of Mirena 52 mg Systems, a contraceptive device, with a completion date of December 26, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items to support the medical supply needs of military health facilities worldwide.
Generated 3/5/25, 9:53 AM